CORD-19:12d35c12218f230c49f4dc892814ba9f1037f251 / 61066-61290
Annnotations
CORD-19_Custom_license_subset
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T53 | 0-224 | Sentence | denotes | A clinical trial investigating the propensity of inducing Treg development through the use of an anti-CD28 super-agonist antibody (TGN1412) resulted in six human volunteers experiencing life-threatening complications (179) . |
CORD-19-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T72822 | 0-224 | Sentence | denotes | A clinical trial investigating the propensity of inducing Treg development through the use of an anti-CD28 super-agonist antibody (TGN1412) resulted in six human volunteers experiencing life-threatening complications (179) . |